MedTrace Logo

Effects of Kinesiotaping in Osteoarthritis

NCT07606157 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-05-26

No results posted yet for this study

Summary

Knee osteoarthritis will be recognized as a leading cause of pain and functional disability, and conventional physiotherapy will remain a cornerstone of its management. Kinesiotaping will be widely used as an adjunct intervention; however, its additional benefit beyond standard rehabilitation programs will remain unclear.

This study will aim to investigate the additional effects of kinesiotaping combined with a conventional physiotherapy and rehabilitation program on pain, functional status, and kinesiophobia in individuals with unilateral knee osteoarthritis.

A total of 60 participants with unilateral knee osteoarthritis will be included in this randomized controlled trial and will be assigned to either a conventional physiotherapy (CP) group or a kinesiotaping (KT) group. Both groups will receive a 4-week (12 sessions) physiotherapy program including ultrasound, transcutaneous electrical nerve stimulation, patellofemoral mobilization, and exercise. Kinesiotaping will be applied every 3 days in the KT group. Outcome measures will include pain (VAS), kinesiophobia (TSK, FABQ), functional performance (30-s sit-to-stand, stair climb test), dynamic balance (functional reach), and WOMAC.

Conditions

  • Osteoarthitis

Interventions

OTHER

Kinesiotaping

Kinesiotaping

Sponsors & Collaborators

  • Nazli Cigercioglu

    lead OTHER

Principal Investigators

  • Cigercioglu · Hacettepe University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-20
Primary Completion
2026-12-20
Completion
2027-06-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07606157 on ClinicalTrials.gov